Aripiprazole
Aripiprazole is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Aripiprazole; Generic name: ARIPIPRAZOLE; Drug class: Atypical Antipsychotic [EPC].
| Brand name | Aripiprazole |
|---|---|
| Generic name | ARIPIPRAZOLE |
| Drug class | Atypical Antipsychotic [EPC] |
| Manufacturer | A-S Medication Solutions |
| Used for | 1 INDICATIONS AND USAGE Aripiprazole Oral Tablets are indicated for the treatment of: Schizophrenia Irritability Associated with Autistic Disorder Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. The oral formulations are indicated for: Schizophrenia ( 14.1 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette’s disorder ( 14.5 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults ( 2.1 ) 10 to 15 mg/day 10 to 15 mg/day 30 mg/day Schizophrenia – adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day Irritability associated with autistic disorder – pediatric patients ( 2.4 ) 2 mg/day 5 to 10 mg/day 15 mg/day Tourette’s disorder – ( 2.5 ) Patients <50 kg 2 mg/day 5 mg/day 10 mg/day Patients ≥50 kg 2 mg/day 10 mg/day 20 mg/day Oral formulations: Administer once daily without regard to mea |
| Warnings | WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS; AND SUICIDAL THOUGHTS AND BEHAVIORS WITH ANTIDEPRESSANT DRUGS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Aripiprazole is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions ( 5.1 )]. Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adu |
| Active ingredient(s) | ARIPIPRAZOLE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13339e7f-a8b4-430d-b623-47372de98348 |